Accurate prediction of the conversion from mild cognitive impairment (MCI) to Alzheimer’s disease (AD) is critically important to slow down the progression to AD with early clinical trials. In this work, this prediction for 3 years is conducted on MRI images shared in Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset. Two powerful image analysis tools, including convolutional neural networks in deep learning and FreeSurfer in brain MRI analysis, are introduced to learn image features which are used for further classification. Cross validation results demonstrate that the proposed approach achieves more accurate and robust prediction comparing with the state-of-the-art grading biomarker method.
This abstract and the presentation materials are available to members only; a login is required.